Surgery Partners, Inc. Common Stock (SGRY) Stock
NASDAQ · SGRY
14.49
Fundamentals
Market cap
$1.89B
Price / Earnings ratio
-21.0x
Price / Sales ratio
0.6x
Price / Book ratio
1.1x
Return on assets
-1.0%
Ex-Dividend date
N/A
Last payment date
N/A
Dividend amount
$0.00
Dividend yield
0.00%
Debt / Equity ratio
N/A
Recent news

Zacks Investment Research
Surgery Partners (SGRY) Soars 15.7%: Is Further Upside Left in the Stock?
NeutralSGRYSeptember 23, 2026
Zacks Investment ResearchNeutral
Surgery Partners (SGRY) Soars 15.7%: Is Further Upside Left in the Stock?
SGRY

The Motley Fool
Surgery Partners Director Teresa DeLuca Buys 11,250 Shares
NeutralSGRYSeptember 3, 2026
The Motley FoolNeutral
Surgery Partners Director Teresa DeLuca Buys 11,250 Shares
SGRY

Zacks Investment Research
Likely ETF & Stock Winners From July Jobs Report
NeutralSGRYAugust 11, 2026
Zacks Investment ResearchNeutral
Likely ETF & Stock Winners From July Jobs Report
SGRY

MarketBeat
Surgery Partners Q2 Earnings Call Highlights
NeutralSGRYAugust 10, 2026
MarketBeatNeutral
Surgery Partners Q2 Earnings Call Highlights
SGRY
Technicals
OscillatorsStrong Buy5 Indicators
Moving AveragesNeutral12 Indicators
Analyst Ratings
Strong Sell0
Sell0
Neutral1
Buy3
Strong Buy0
Financials
Performance
Revenue
Net income
Net margin %
2025
4B3B1B0
Debt & Balance Sheet
Total assets
Total liabilities
2025
10B6B3B0
Revenue to Profit
2025$3.3B
Revenue$0.0
Cost of revenue$0.0
Gross profit$0.0
Operating expenses$-77.9M
Net incomeEarnings
EPS forecast
Actual EPS
$-0.02
Q1FY26
$0.08
Q2FY26
The market is expecting earnings per share of $0.08 for this quarter. The company has not yet shared when it is announcing earnings.
% positive news of 10 articles
published over the past 14 days
Latest news

Zacks Investment Research
Surgery Partners (SGRY) Soars 15.7%: Is Further Upside Left in the Stock?
NeutralSGRYSeptember 23, 2026
Zacks Investment ResearchNeutral
Surgery Partners (SGRY) Soars 15.7%: Is Further Upside Left in the Stock?
SGRY

The Motley Fool
Surgery Partners Director Teresa DeLuca Buys 11,250 Shares
NeutralSGRYSeptember 3, 2026
The Motley FoolNeutral
Surgery Partners Director Teresa DeLuca Buys 11,250 Shares
SGRY

Zacks Investment Research
Likely ETF & Stock Winners From July Jobs Report
NeutralSGRYAugust 11, 2026
Zacks Investment ResearchNeutral
Likely ETF & Stock Winners From July Jobs Report
SGRY

MarketBeat
Surgery Partners Q2 Earnings Call Highlights
NeutralSGRYAugust 10, 2026
MarketBeatNeutral
Surgery Partners Q2 Earnings Call Highlights
SGRY

Zacks Investment Research
Surgery Partners (SGRY) Q2 Earnings and Revenues Beat Estimates
NeutralSGRYAugust 10, 2026
Zacks Investment ResearchNeutral
Surgery Partners (SGRY) Q2 Earnings and Revenues Beat Estimates
SGRY

Zacks Investment Research
Strength Seen in Surgery Partners (SGRY): Can Its 5.3% Jump Turn into More Strength?
NeutralSGRYJuly 30, 2026
Zacks Investment ResearchNeutral
Strength Seen in Surgery Partners (SGRY): Can Its 5.3% Jump Turn into More Strength?
SGRY

Zacks Investment Research
Fast-paced Momentum Stock Surgery Partners (SGRY) Is Still Trading at a Bargain
NeutralSGRYJuly 8, 2026
Zacks Investment ResearchNeutral
Fast-paced Momentum Stock Surgery Partners (SGRY) Is Still Trading at a Bargain
SGRY

Zacks Investment Research
Why Fast-paced Mover Surgery Partners (SGRY) Is a Great Choice for Value Investors
NeutralSGRYJune 22, 2026
Zacks Investment ResearchNeutral
Why Fast-paced Mover Surgery Partners (SGRY) Is a Great Choice for Value Investors
SGRY

Zacks Investment Research
Wall Street Analysts See a 26.14% Upside in Surgery Partners (SGRY): Can the Stock Really Move This High?
NeutralSGRYJune 18, 2026
Zacks Investment ResearchNeutral
Wall Street Analysts See a 26.14% Upside in Surgery Partners (SGRY): Can the Stock Really Move This High?
SGRY

The Motley Fool
Surgery Partners vs. Viemed Healthcare: Which Outpatient Care Stock Is a Better Buy in 2026?
NeutralSGRYJune 10, 2026
The Motley FoolNeutral
Surgery Partners vs. Viemed Healthcare: Which Outpatient Care Stock Is a Better Buy in 2026?
SGRY
About Surgery Partners, Inc. Common Stock
No description available.
SectorHealthcare
IndustryMedical Care Facilities
Employees16,000
CEOMr. J. Eric Evans
IPO DateOct 1, 2015
HeadquartersBrentwood, TN
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. J. Eric Evans | CEO & Director | 1977 |
| Mr. David T. Doherty CPA | Executive VP & CFO | 1972 |
| Ms. Jennifer B. Baldock J.D. | Executive VP and Chief Administrative & Development Officer | 1971 |
| Ms. Marissa A. Brittenham | Executive VP & Chief Strategy Officer | 1985 |
| Mr. W. Trent Webb | Division President South | 1980 |
| Mr. Justin R. Oppenheimer | Executive VP & COO | 1985 |
| Mr. Jon Fredrickson | Senior VP & Chief Information Officer | — |
| Ms. Roxanne Womack | Senior VP & Chief Compliance Officer | — |
| Mr. Spencer Clark | General Counsel & Senior VP | — |
| Ms. Danielle Burkhalter | Executive VP & Chief Human Resources Officer | 1985 |
Fundamentals
Valuation
Market cap$1.89B
Price-to-sales ratio0.55
Price-to-book value1.11
Price-earnings ratio-21.00
Return on Equity-4.00%
Return on Sales7.00%
Return on Assets-1.00%
PEG ratio1.66
Earnings Per Share
Earnings Per Share$-0.69
Income Statement
Average volume2,654,904
EBITDA$437.80M
1 year high (52w)$23.44
1 year low (52w)$11.41
Dividend
Ex dividend dateN/A
Dividend amount$0.00
Dividend yield0.00%
Last payment dateN/A
Dividend yield (TTM)N/A
Next earnings reportN/A
Solvency
Debt-to-equity ratioN/A
Technicals
OscillatorsStrong Buy5 Indicators
Moving AveragesNeutral12 Indicators
What the experts say
4 Wall Street Analyst Ratings
BUY
75% Buy
25% Hold
0% Sell
Target price
$17.75
Est return
23.18%
Seasonality
Monthly price change (%)| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | +0.0 | -8.8 | +8.8 | +26.1 | ||||||||
| 2022 | -22.5 | +16.7 | +1.1 | -7.7 | -23.5 | -23.3 | +25.9 | -26.7 | -10.2 | +9.4 | +0.6 | -2.5 |
| 2023 | +26.2 | -3.5 | +1.4 | +14.9 | -4.8 | +17.9 | -11.5 | -1.8 | -21.7 | -20.9 | +44.6 | -6.0 |
| 2024 | -3.0 | -4.6 | -4.4 | -13.6 | +12.1 | -10.2 | +29.7 | +5.7 | +2.6 | -11.4 | -17.1 | -11.1 |
| 2025 | +19.7 | -4.8 | -1.0 | -6.5 | +5.3 | -5.0 | -2.7 | +6.6 | -4.2 | +3.5 | -21.3 | -9.6 |
| 2026 | -2.6 | +4.7 | -24.9 | +14.4 | -6.4 | +27.1 | -7.2 | -13.5 | -1.4 |



